The effect of valinomycin in fibroblasts from patients with fatty acid oxidation disorders
Uzochi Chimdinma Ndukwe Erlingsson(University of Utah), Nicola Longo(Center for Human Genetics), Francesco Iacobazzi(University of Bari Aldo Moro), Orly Ardon(Memorial Sloan Kettering Cancer Center), Marzia Pasquali(University of Utah), Aiping Liu(ARUP Laboratories (United States))
Cited by 10
Related Papers
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555
Validation of a digital pathology system including remote review during the COVID-19 pandemic
|Modern Pathology|2020|184
Desferrioxamine-mediated Iron Uptake in Saccharomyces cerevisiae
|Journal of Biological Chemistry|2000|183
Fluorescently-Labeled Ferrichrome Analogs as Probes for Receptor-Mediated, Microbial Iron Uptake
|Journal of the American Chemical Society|1996|174
HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system
|Virology Journal|2007|152